Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients

• المؤلفون الرئيسيون: Bouazza N., Cressey T., Foissac F., Bienczak A., Denti P., McIlleron H., Burger D., Penazzato M., Lallemant M., Capparelli E., Treluyer J., Urien S.
• التنسيق: دورية
• منشور في: 2017
• الوصول للمادة أونلاين: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85014551564&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41174

© The Author 2016. Background: Child-friendly, low-cost, solid, oral fixed-dose combinations (FDCs) of efavirenz with lamivudine and abacavir are urgently needed to improve clinical management and drug adherence for children. Methods: Data were pooled from several clinical trials and therapeutic dru...